/Lists

Late Stage Investors & VC Firms in Germany

98 firms in this list, with a median first check of $2.3M. 29 of them lead rounds. Generated from verified public data and updated continuously.

3i Group
LondonGrowth–Late Stage
136 people
Altor
StockholmGrowth–Late Stage
101 people
Gimv
AntwerpGrowth–Late Stage$21M – $430M
101 people
Atomico
LondonSeed–Late Stage
37 people
BU Fund IV
ZugGrowth–Late Stage$110M – $550M
90 people
Argos Wityu
ParisGrowth–Late Stage
86 people
Advent International
BostonGrowth–Late Stage$1.1B
66 people
Axcel Management A/S
CopenhagenGrowth–Late Stage
74 people
EQT Life Sciences
AmsterdamSeed–Late Stage$11M – $66M
59 people
Activant Capital
New YorkSeed–Late Stage$3M – $40M
25 people
Pfizer Venture Investments
New YorkSeed–Late Stage$5M – $20M
18 people
Korys
HalleGrowth–Late Stage$5.4M
45 people
Eurazeo
ParisSeed–Late Stage
35 people
Forbion
NaardenPre-Seed–Late Stage
25 people
Iris Capital
ParisSeed–Late Stage$1.1M – $32.4M
31 people
Verium AG
ZurichGrowth–Late Stage$10M
44 people
BioGeneration Ventures
NaardenPre-Seed–Late Stage
34 people
Asahi Kasei Corporate Venture Capital
Menlo ParkPre-Seed–Late Stage$200K – $5M
25 people
Cloud Capital
WashingtonSeed–Late Stage
34 people
Cipio Partners
SenningerbergSeries B–Late Stage$5M – $15M
20 people
Casa Verde Capital
West HollywoodPre-Seed–Late Stage
19 people
Princeville Capital
San FranciscoSeries A–Late Stage
28 people
Ajax Health
Menlo ParkSeed–Late Stage
29 people
Nordic Capital
StockholmGrowth–Late Stage
17 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.